International Australian researchers granted $3M for psychedelic mental health treatments Two separate trials will look at MDMA for alcohol use and PTSD, as well as psilocybin-assisted therapy for anorexia nervosa Nick LabaJanuary 17, 2022
Canada ATMA to run clinical trial for synthetic psilocybin on medical professionals Following the trial's approval from Health Canada, psychedelic practitioners can now apply to be research subjects Natalia Buendia CalvilloJanuary 11, 2022
Canada Health Canada says patients should access medical psilocybin via clinical trials When asked why patient requests for legal psilocybin are being denied or delayed, the agency said studies are the best route for access Natalia Buendia CalvilloAugust 11, 2021
Canada Advocacy group drafts medical psilocybin framework for regulated access TheraPsil's CEO expects change for psilocybin to come in a matter of months because of the work done for cannabis Kathryn TindaleAugust 4, 2021
Medical and Pharmaceutical Psilocybin treats depression as well as common antidepressant: study The first head-to-head clinical trial pushes the psychedelic compound closer to becoming a licensed medicine Jared GnamApril 15, 2021
Industry update Canada’s first set of approved health workers begin psilocybin therapy training 15 trainees started a beta program this week, designed and run by advocacy group TheraPsil Natalia Buendia CalvilloMarch 2, 2021